Skip to content
Medical Health Aged Care

Come walk or jog with us in Bowral! We are in this together!

Dementia Australia 2 mins read

The 2024 Bowral Memory Walk & Jog is nearly here with the event taking place on Sunday 18 February at the Botanic Gardens.

 

Dementia Australia’s largest fundraising event hopes to attract thousands of people across Australia to help raise more than $2 million in support of people living with dementia. Funds raised at our upcoming event in Bowral will help advance the work of Dementia Australia which delivers invaluable support, education and resources for people living with dementia, their families and carers.

 

Memory Walk & Jog is about being part of the community and feeling supported. We are in this together, which is why participants can walk, jog or run and select from either 4km or 8km.

 

Registrations for the Bowral Memory Walk & Jog are still open and we’d love to see as many people as possible walking, jogging, or running at the Botanic Gardens. It’s a great day out, raising money and awareness for such an important cause.

 

Dementia Australia spokespeople and a local participant are available for media stories. Please contact Ash Blakemore, Senior Media & Communications Advisor, 0448 170 672, [email protected].

 

Walk or jog with us. We are in this together. 

 

Sign-up to walk, jog or run or join in as a volunteer at a Memory Walk & Jog event at www.memorywalk.com.au. Share your Memory Walk & Jog experience on your socials and Donate today to support people living with dementia across Australia. 

 

If you can’t attend an event, why not organise your own group or individual walk or jog, with a MyWay event. Choose your own date and location and register at www.memorywalk.com.au/get-involved/mw.

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.  

 

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au   

 

-Ends-

Media contacts: Ash Blakemore, Senior Media & Communications Advisor, 0448 170 672, [email protected]. Andrea Hogan, Media and Communications Manager, 0406 904 118, [email protected]

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Business Company News, Medical Health Aged Care
  • 13/01/2026
  • 10:50
Nova Eye Medical (ASX:EYE)

Nova Eye Medical Reports Record Sales Result for December 2025 Quarter

HIGHLIGHTS Record December quarter with global sales of US$6.1 million, up 38% on pcp and 25% on the September 2025 quarter Global six-month sales…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 13/01/2026
  • 10:09
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Reports Clinical Response for StemSmart(TM) Treatment in Fistulising Crohn’s Disease Under Special Access Program

13 January 2026 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced a “Clinical Response” from patients treated with its patented StemSmart™ Mesenchymal Stem Cell (MSC) therapy under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) for fistulising Crohn’s disease. Three of four patients treated in Cohort 1 of the Special Access Program demonstrated a successful “Clinical Response” following treatment with StemSmart™, with the fourth patient showing a partial response with further clinical assessment needed. A Clinical Response is defined as either closure of at least 50 per cent of fistula openings or a reduction in fistula…

  • Contains:
  • Medical Health Aged Care
  • 13/01/2026
  • 10:08
Dementia Australia

Community grants to boost dementia-friendly initiatives across Australia

Dementia Australia has today opened applications foranewround ofCommunity Engagementgrantsforup to12dementia-friendly community initiatives. Dementia Australia CEO Professor Tanya Buchanan saidcommunity groupscouldapply for up to $10,000for…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.